Medical treatment of glaucoma: present and future

P Fogagnolo, L Rossetti - Expert opinion on investigational drugs, 2011 - Taylor & Francis
Introduction: In the last decades, the therapy of glaucoma has largely shifted from surgery to
medical treatment thanks to the introduction of strongly effective formulations, that is …

Perspectives in the medical treatment of glaucoma

WC Stewart - Current Opinion in Ophthalmology, 1999 - journals.lww.com
Many advances in medical therapy for chronic glaucoma have taken place in the past few
years that have altered previous concepts of stepwise medical therapy for glaucoma. β …

Advances in medical therapy for glaucoma

E Ostler, D Rhee, E Burney… - Current Opinion in …, 2021 - journals.lww.com
Newer medications may be able to extend the duration of medically controlled glaucoma,
delaying or possibly eliminating the need of glaucoma surgery for some patients. Alternative …

Advances in glaucoma therapeutics

IH Pang, AF Clark - Expert opinion on emerging drugs, 2002 - Taylor & Francis
Glaucoma is a major cause of irreversible blindness in the world. The prevalence of
glaucomatous loss in vision will continue to grow as our populations age. Ocular …

Pharmacotherapy of glaucoma

D Schmidl, L Schmetterer, G Garhöfer… - Journal of Ocular …, 2015 - liebertpub.com
Glaucoma is a group of diseases involving the optic nerve and associated structures, which
is characterized by progressive visual field loss and typical changes of the optic nerve head …

Achievements and limits of current medical therapy of glaucoma

P Kalouda, C Keskini, E Anastasopoulos… - Glaucoma surgery, 2017 - karger.com
Prescribing medical therapy for the treatment of glaucoma can be a complex process since
many parameters should be taken into consideration regarding its achievements and limits …

Current and emerging medical therapies in the treatment of glaucoma

A Bagnis, M Papadia, R Scotto… - Expert opinion on …, 2011 - Taylor & Francis
Introduction: Glaucoma is a disease of the eye in which the optic nerve and retinal ganglion
cells (RGCs) are injured, leading to the loss of the peripheral visual field and eventually to …

Novel therapies for glaucoma: a patent review 2007–2011

F Carta, CT Supuran, A Scozzafava - Expert opinion on therapeutic …, 2012 - Taylor & Francis
Introduction: Glaucoma affects a large number of people, and therapies for its management
are based on the use of adrenergic agonist/antagonists, carbonic anhydrase (CA) inhibitors …

New pharmacotherapy for the treatment of glaucoma

EM Schehlein, G Novack, AL Robin - Expert Opinion on …, 2017 - Taylor & Francis
Introduction: Glaucoma is the second leading cause of blindness in the world and current
pharmacotherapies for glaucoma have remained relatively unchanged (with the exception of …

Status and perspectives of neuroprotective therapies in glaucoma: the European Glaucoma Society White Paper

ER Tamm, L Schmetterer, F Grehn - Cell and tissue research, 2013 - Springer
Glaucoma, a chronic progressive neuropathy and the most frequent cause of irreversible
blindness worldwide, is commonly treated by medication or surgery aimed at lowering …